3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Unknown
1
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
43
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm, Residual
1
Interventions
Blood Specimen Collection
121
Surveys and Questionnaires
83
Observation
50
Radiotherapy
40
Drug Therapy
35
Surgical Procedures, Operative
34
Biopsy
31
Specimen Handling
28
Data Collection
28
Watchful Waiting
21
Interviews as Topic
20
Immune Checkpoint Inhibitors
19
Magnetic Resonance Imaging
18
Liquid Biopsy
16
Immunotherapy
15
Magnetic Resonance Spectroscopy
14
Standard of Care
13
pembrolizumab
12
Tomography, X-Ray Computed
12
Ultrasonography
11
trastuzumab deruxtecan
10
lenvatinib
10
Radiosurgery
10
Nivolumab
10
Carboplatin
10
Tissue Banks
9
Restraint, Physical
9
Radiation
9
Neoadjuvant Therapy
9
Endoscopy
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Observational
×
Daunorubicin
×
Clear all
NCT05959720
2025-05-07
BRALLA
Instituto do Cancer do Estado de São Paulo
Recruiting
180 enrolled